Document is current
Any future updates will be listed below
-
Authors
Deng, Qiong
Du, Fangzhou
Pan, Shenzhen
Xia, Yuchen
Zhu, Yuxin
Zhang, Jingzhong
Li, Chenglong
Yu, Shuang https://orcid.org/0000-0002-5604-0293
-
Funding
Funding for this research was provided by:
National Key Research and Development Program of China (No. 2021YFA1101100, No. 2022YFA1104800)
Innovative Research Group Project of the National Natural Science Foundation of China (No. 82271522)
Basic Research Priorities Program of Jiangsu Province (No. BK20243003)
Basic Research Program of Suzhou (No. SSD2024019)
- License Information
-
More Information
Article History
Received: 13 November 2024
Accepted: 29 January 2025
First Online: 21 February 2025
Declarations
:
: Animal experiments: (1) Animal experiment for the efficacy of mesenchymal stem cells in diabetic wound healing. (2) The Ethics Committee for Experimental Animals of Suzhou Institute of Biomedical Engineering Technology, Chinese Academy of Sciences. (3) 2021 − B13. (4) 16/3/2021. The protocols for animal experiments adhere to the ARRIVE (Animal Research: Reporting of in Vivo Experiments) guidelines. Human sample: (1) Fresh MSCs of human was obtained from donors for effectiveness of stem cell therapy. (2) The Ethics Committee of the First Affiliated Hospital of Soochow University. (3) 2019 − 136. (4) 30/12/2019. Patient provided written informed consent for the use of samples. Human MSCs were isolated from donated human umbilical cord after obtaining permission for their use in research applications by informed consent or legal authorization
: Not applicable.
: The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
